121 related articles for article (PubMed ID: 28978860)
1. [Development of iPS cell-derived blood products and production guidelines].
Sugimoto N; Eto K
Rinsho Ketsueki; 2017; 58(10):2150-2159. PubMed ID: 28978860
[TBL] [Abstract][Full Text] [Related]
2. [Ex vivo platelet production from induced pluripotent stem cells].
Sugimoto N; Eto K
Rinsho Ketsueki; 2018; 59(10):1905-1913. PubMed ID: 30305491
[TBL] [Abstract][Full Text] [Related]
3. Induced Pluripotent Stem Cell-Derived Red Blood Cells and Platelet Concentrates: From Bench to Bedside.
Focosi D; Amabile G
Cells; 2017 Dec; 7(1):. PubMed ID: 29280988
[TBL] [Abstract][Full Text] [Related]
4. Platelet production from induced pluripotent stem cells.
Sugimoto N; Eto K
J Thromb Haemost; 2017 Sep; 15(9):1717-1727. PubMed ID: 28752663
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo generation of platelet products from human iPS cells.
Nakamura S; Sugimoto N; Eto K
Inflamm Regen; 2020 Dec; 40(1):30. PubMed ID: 33292717
[TBL] [Abstract][Full Text] [Related]
6. [Novel platelet pharming using human induced pluripotent stem cells].
Flahou C; Sugimoto N; Eto K
Bull Acad Natl Med; 2020 Dec; 204(9):961-970. PubMed ID: 33012790
[TBL] [Abstract][Full Text] [Related]
7. Generation and manipulation of human iPSC-derived platelets.
Sugimoto N; Eto K
Cell Mol Life Sci; 2021 Apr; 78(7):3385-3401. PubMed ID: 33439272
[TBL] [Abstract][Full Text] [Related]
8. [Novel physico-chemical regulation mechanism enables the production of 100 billion platelets].
Nakamura S; Eto K
Rinsho Ketsueki; 2020; 61(6):628-633. PubMed ID: 32624536
[TBL] [Abstract][Full Text] [Related]
9. Platelets using iPS cell technology; large scale manufacturing.
Eto K
J Stem Cells Regen Med; 2019; 15(2):52. PubMed ID: 31983858
[TBL] [Abstract][Full Text] [Related]
10. Turbulence Activates Platelet Biogenesis to Enable Clinical Scale Ex Vivo Production.
Ito Y; Nakamura S; Sugimoto N; Shigemori T; Kato Y; Ohno M; Sakuma S; Ito K; Kumon H; Hirose H; Okamoto H; Nogawa M; Iwasaki M; Kihara S; Fujio K; Matsumoto T; Higashi N; Hashimoto K; Sawaguchi A; Harimoto KI; Nakagawa M; Yamamoto T; Handa M; Watanabe N; Nishi E; Arai F; Nishimura S; Eto K
Cell; 2018 Jul; 174(3):636-648.e18. PubMed ID: 30017246
[TBL] [Abstract][Full Text] [Related]
11. [Clinical applications of iPS cell-derived platelets].
Sugimoto N; Eto K
Rinsho Ketsueki; 2022; 63(10):1430-1439. PubMed ID: 36351652
[TBL] [Abstract][Full Text] [Related]
12. Production and nonclinical evaluation of an autologous iPSC-derived platelet product for the iPLAT1 clinical trial.
Sugimoto N; Nakamura S; Shimizu S; Shigemasa A; Kanda J; Matsuyama N; Tanaka M; Hayashi T; Fuchizaki A; Nogawa M; Watanabe N; Okamoto S; Handa M; Sawaguchi A; Momose D; Koh KR; Tani Y; Takaori-Kondo A; Eto K
Blood Adv; 2022 Dec; 6(23):6056-6069. PubMed ID: 36149941
[TBL] [Abstract][Full Text] [Related]
13. [Progress towards development of a platelet transfusion product employing iPS cells].
Suzuki D; Eto K
Rinsho Ketsueki; 2016 Mar; 57(3):308-14. PubMed ID: 27076243
[TBL] [Abstract][Full Text] [Related]
14. Toward in Vitro Production of Platelet from Induced Pluripotent Stem Cells.
Izady E; Saltanatpour Z; Liu LP; Alizadeh A; Hamidieh AA
Stem Cell Rev Rep; 2022 Oct; 18(7):2376-2387. PubMed ID: 35397051
[TBL] [Abstract][Full Text] [Related]
15. [Reconstitution of the hematopoietic system and clinical applications of iPS cells].
Sugimoto N; Eto K
Rinsho Ketsueki; 2019; 60(9):1046-1055. PubMed ID: 31597826
[TBL] [Abstract][Full Text] [Related]
16. Development of platelet replacement therapy using human induced pluripotent stem cells.
Nakamura S; Sugimoto N; Eto K
Dev Growth Differ; 2021 Feb; 63(2):178-186. PubMed ID: 33507533
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo manufacturing of platelets: beyond the first-in-human clinical trial using autologous iPSC-platelets.
Chen SJ; Sugimoto N; Eto K
Int J Hematol; 2023 Mar; 117(3):349-355. PubMed ID: 36574167
[TBL] [Abstract][Full Text] [Related]
18. Human-induced pluripotent stem cell-derived blood products: state of the art and future directions.
Hansen M; von Lindern M; van den Akker E; Varga E
FEBS Lett; 2019 Dec; 593(23):3288-3303. PubMed ID: 31520530
[TBL] [Abstract][Full Text] [Related]
19. Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells.
Nakamura S; Takayama N; Hirata S; Seo H; Endo H; Ochi K; Fujita K; Koike T; Harimoto K; Dohda T; Watanabe A; Okita K; Takahashi N; Sawaguchi A; Yamanaka S; Nakauchi H; Nishimura S; Eto K
Cell Stem Cell; 2014 Apr; 14(4):535-48. PubMed ID: 24529595
[TBL] [Abstract][Full Text] [Related]
20. [Potential usefulness of human iPS cells on the generation of platelets].
Takayama N; Eto K; Nakauchi H
Nihon Rinsho; 2011 Dec; 69(12):2161-5. PubMed ID: 22242314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
